LINC01133 is upregulated in HCC, interacting with annexin A2 (ANXA2) and activating ANXA2/STAT3/cyclinD1 signaling which, in turn, promotes HCC progression. This evidence concerns the gene ANXA2 and hepatocellular carcinoma.